.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Johnson and Johnson
Fuji
Queensland Health
McKesson
US Department of Justice
US Army
UBS
Julphar

Generated: November 22, 2017

DrugPatentWatch Database Preview

BUTABARB Drug Profile

« Back to Dashboard

What is the patent landscape for Butabarb, and what generic Butabarb alternatives are available?

Butabarb is a drug marketed by Alpharma Us Pharms, Bundy, Solvay, Whiteworth Town Plsn, Teva, Sandoz, Watson Labs, and Wockhardt. and is included in seventeen NDAs.

The generic ingredient in BUTABARB is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms
BUTABARB
butabarbital sodium
ELIXIR;ORAL085873-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL085934-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town Plsn
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083325-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL085772-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town Plsn
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083337-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083897-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL084292-003Feb 9, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bundy
BUTABARBITAL
butabarbital sodium
TABLET;ORAL085550-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083606-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL088632-001May 18, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cerilliant
Cipla
Medtronic
Merck
Express Scripts
Citi
Teva
Daiichi Sankyo
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot